# Immunologic Memory (Supp. of ATN 024)

> **NCT00142753** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 95 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Engerix B
- **BIOLOGICAL:** Twinrix for ATN 024
- **BIOLOGICAL:** Recombivax
- **BIOLOGICAL:** Twinrix for ATN 025

## Key facts

- **NCT ID:** NCT00142753
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2017-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142753, "Immunologic Memory (Supp. of ATN 024)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00142753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*